| Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study. | |
| | |
MedLine Citation:
|
PMID: 20393695 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: We undertook a study investigating whether immigrants from Turkey, Pakistan and Yugoslavia received adequate medical treatment with beta-blockers and statins after acute myocardial infarction (AMI) when compared with Danish-born residents and explored whether associations between patient origin and medical treatment were mediated by socioeconomic status (SES). METHODS: This register-based follow-up study consisted of individuals >17 years of age, admitted to hospital with AMI between 2001 and 2005 (n=25,443). Danish-born residents were compared with immigrants from Turkey, Pakistan and Yugoslavia. Individuals were identified by civil registration number, and data were obtained through linkage to the national registers of hospitalisations and drug prescriptions. Odds of initiating treatment and hazard ratios (HR) of terminating treatment were estimated. Mediators such as income and employment were included in the models. RESULTS: Pakistanis were less likely than Danish-born residents to initiate treatment with beta-blockers after AMI [odds ratio 0.52; 95% confidence interval (CI) 0.34-0.80]. Immigrants from Turkey (HR 1.36; 95% CI 1.07-1.73) and Pakistan (HR 1.59; 95% CI 1.21-2.08) were more likely to terminate treatment with beta-blockers before being recommended to do so. Estimates did not change markedly when income and education were included in the models. CONCLUSIONS: The results of this study suggest that immigrants from Pakistan and Turkey do not receive adequate medical treatment with beta-blockers after a first AMI compared with Danish-born residents. Mediators such as income and employment may not be sufficient indicators of SES when the effect of patient origin on medical treatment is explored. A lower SES of immigrants, communication problems between doctor and patient and doctors' attitudes towards immigrants may explain ethnic differences in medical treatment after AMI. |
| | |
Authors:
|
Nana Folmann Hempler; Finn Diderichsen; Finn Breinholt Larsen; Steen Ladelund; Torben Jørgensen |
Related Documents
:
|
17044015 - Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder... 11444405 - Clostridium difficile-associated diarrhea and colitis. 18399445 - Survey of weed composition befor maize sowing in long-term fertilization experiment. 15279125 - Evolving use of buprenorphine in the treatment of addiction. 12098365 - The journal club in postgraduate medical education: a systematic review. 12354795 - Clinical pathology accreditation: standards for the medical laboratory. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European journal of clinical pharmacology Volume: 66 ISSN: 1432-1041 ISO Abbreviation: Eur. J. Clin. Pharmacol. Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-06-17 Completed Date: 2010-09-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1256165 Medline TA: Eur J Clin Pharmacol Country: Germany |
Other Details:
|
Languages: eng Pagination: 735-42 Citation Subset: IM |
Affiliation:
|
Research Centre for Prevention and Health, Capital Region of Denmark, Glostrup University Hospital, Building 84/85, DK-2600 Glostrup, Denmark. nabf@glo.regionh.dk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adolescent Adrenergic beta-Antagonists / therapeutic use* Adult Denmark Emigrants and Immigrants* Female Follow-Up Studies Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Male Medication Adherence Middle Aged Models, Statistical Myocardial Infarction / drug therapy*, ethnology* Pakistan / ethnology Social Class Turkey / ethnology Yugoslavia / ethnology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effects of periarticular steroid injection on knee function and the inflammatory response following ...
Next Document: Effect of glycyrrhizin on the activity of CYP3A enzyme in humans.